Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Prina Donga"'
Autor:
Peter F. Rebeiro, Bruno Emond, Carmine Rossi, Brahim K. Bookhart, Aditi Shah, Gabrielle Caron‐Lapointe, Marie‐Hélène Lafeuille, Prina Donga
Publikováno v:
Journal of the International AIDS Society, Vol 26, Iss 6, Pp n/a-n/a (2023)
Abstract Introduction Integrase strand transfer inhibitor (INSTI)‐containing antiretroviral therapy (ART) has been associated with weight gain, though there is limited information on associations between ART‐related weight gain and cardiometaboli
Externí odkaz:
https://doaj.org/article/b09983ffb67848e29a814a9c2b9f6848
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 10, Iss 1 (2023)
**Background:** With advances in antiretroviral therapy (ART), people with HIV infection are living longer. Pre-exposure prophylaxis (PrEP) to reduce HIV infection risk continues to be underutilized in high-risk individuals. Recent data on economic b
Externí odkaz:
https://doaj.org/article/98c7c012b60f457b981843d6ebf1d24b
Autor:
Prina Donga, Bruno Emond, Aditi Shah, Brahim K Bookhart, David Anderson, Maude Vermette-Laforme, Carmine Rossi, Marie-Helene Lafeuille
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 1 (2022)
Aim: Compare weight changes between people living with HIV-1 (PLWH) at high risk of weight gain (females, Blacks or Hispanics) switching from an integrase strand transfer inhibitor (INSTI) to a protease inhibitor (PI) or another INSTI. Materials &
Externí odkaz:
https://doaj.org/article/b541c14e9798497fb026360a3786df8b
Autor:
Bruno Emond, Carmine Rossi, Rachel Rogers, Patrick Lefebvre, Marie-Hélène Lafeuille, Prina Donga
Publikováno v:
Journal of Health Economics and Outcomes Research (2022)
**Background:** While some studies among patients with HIV-1 suggest that antiretroviral therapy (ART) regimens containing tenofovir alafenamide (TAF) may be associated with greater weight gain than those not containing TAF, no studies have assessed
Externí odkaz:
https://doaj.org/article/b3d47311a04b418bb651e929bd8ef1b1
Publikováno v:
Journal of Health Economics and Outcomes Research (2022)
**Background:** Studies have shown an increase in weight among people living with HIV (PLWH) who initiated integrase strand transfer inhibitors (INSTI). However, weight gain with INSTI-based regimens vs other regimens in females or racial/ethnic mino
Externí odkaz:
https://doaj.org/article/973642c0076d4923808abc7669bd1dd8
Autor:
Bruno Emond, Carmine Rossi, Aurélie Côté-Sergent, Keith Dunn, Patrick Lefebvre, Marie-Hélène Lafeuille, Prina Donga
Publikováno v:
Journal of Health Economics and Outcomes Research (2021)
**Background:** Recent evidence suggests that integrase strand transfer inhibitors are associated with greater weight gain than protease inhibitors in patients with human immunodeficiency virus (HIV-1). **Objectives:** To describe demographic and cl
Externí odkaz:
https://doaj.org/article/7b732fe6b8aa4115b01006205a2277ee
Autor:
Emily Shortridge PhD, Craig Donatucci MD, Prina Donga MS, Michael Marcus MS, Rolin L. Wade MS, RPh
Publikováno v:
American Journal of Men's Health, Vol 11 (2017)
Medication adherence and persistence patterns among patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) were analyzed. Electronic medical records of patients from the Reliant Medical Group were examined to evaluate adhe
Externí odkaz:
https://doaj.org/article/c38ef54c9efc4e96ad8fc17b81bcc3a5
Autor:
Babafemi O, Taiwo, Hela, Romdhani, Marie-Hélène, Lafeuille, Rhea, Bhojwani, Katherine, Milbers, Prina, Donga
Publikováno v:
Journal of Drug Assessment. 12:1-11
As the human immunodeficiency virus (HIV) treatment landscape continues to evolve, the prolonged life expectancy and long-term exposure to antiretroviral drugs have modified the burden associated with living with HIV.To better understand the current
Autor:
Grace A. McComsey, Bruno Emond, Aditi Shah, Brahim K. Bookhart, Carmine Rossi, Katherine Milbers, Marie-Hélène Lafeuille, Prina Donga
Publikováno v:
Infectious Diseases and Therapy. 11:1883-1899
Antiretroviral therapy (ART) has been associated with weight gain in people living with HIV-1 (PLWH); however, limited research has assessed whether early weight gain post-ART initiation is associated with metabolic or cardiovascular outcomes among P
Publikováno v:
The Primary Care Companion For CNS Disorders. 25